Curves Holdings (7085) · RiskFirst stated

Risk of Termination or Non-Renewal of Protein Manufacturing Outsourcing Agreement

First written in FY2022. . Latest entry: FY2022.

1entries

1years

0from disclosures

Share on X

How it moved

Same theme, other companies

Reliance on an Outsourced Production SystemA theme 43 companies write about · 43 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2020: 4 of 20 companies on the "Worse" side.

4 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 43 companies compared. The sentences above are computed from all 43.

Full recordFilings, disclosures and news, newest first

FY2022First statedAnnual report
「However, if an event occurs that constitutes grounds for termination described above, or if the agreement cannot be renewed, it could affect the business performance of the Group. For the manufacturing outsourcing agreement with 日成共益株式会社, please refer to “Part II. Business Overview, 4. Material Agreements Relating to Management.”」
The risk that termination or inability to renew the protein manufacturing outsourcing agreement, due to issues under the Pharmaceutical and Medical Device Act or other reasons, could affect business performance is explicitly disclosed for the first time.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

Curves Holdings's next results are scheduled for 2026-10-13. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.